Mahwash Mukhtar is currently in her third year of PhD study at the Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Hungary. She obtained her Bachelor’s degree in Pharmacy (Pharm.D) with distinction from The University of Lahore, Pakistan. After graduation, she joined Dr. Hussain Ali’s research team at Quaid-i-Azam University Islamabad, Pakistan, and acquired a Master’s of Philosophy (M.Phil) degree in Pharmaceutics. The topic of her research was macrophage targeted nano-mediated delivery of anti-inflammatory drugs. She was awarded a University fellowship and Fazaia Educational Welfare Scheme (FEWS) scholarship during this period of research. Later, she was awarded the Stipendium Hungaricum scholarship for pursuing a doctorate in the lab of Dr. Rita Ambrus. The current topic of her research focuses on nanotechnology-based pulmonary dry powder inhalers for Tuberculosis. She is also a part of the SZTE Nanotechnological Research Group in Interdisciplinary Centre of Excellence, University of Szeged, Hungary. She has published one book chapter and five peer-review papers (with three as the first author) in the International Journal of Biological Macromolecules, Expert Opinion on Drug Delivery, Nanomedicine, etc. Three other articles are in press in the peer-reviewed journals. She has presented her work as an oral presentation at various national and international conferences like EUGLOH Annual Student Research Conference 2020, Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology, and Regulatory Science 2020, etc.